Compare · HUM vs KEQU
HUM vs KEQU
Side-by-side comparison of Humana Inc. (HUM) and Kewaunee Scientific Corporation (KEQU): market cap, price performance, sector, and recent activity on the wire.
Summary
- HUM operates in Health Care, while KEQU operates in Industrials - the two are in different parts of the market.
- HUM is the larger of the two at $46.80B, about 432.8x KEQU ($108.1M).
- Over the past year, HUM is up 30.1% and KEQU is down 38.4% - HUM leads by 68.5 points.
- HUM has been more active in the news (6 items in the past 4 weeks vs 2 for KEQU).
- HUM has more recent analyst coverage (25 ratings vs 0 for KEQU).
- Company
- Humana Inc.
- Kewaunee Scientific Corporation
- Price
- $388.85+0.65%
- $35.90-2.37%
- Market cap
- $46.80B
- $108.1M
- 1M return
- +2.03%
- -1.56%
- 1Y return
- +30.12%
- -38.42%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 6
- 2
- Recent ratings
- 25
- 0
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Kewaunee Scientific Corporation
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. It operates in two segments, Domestic and International. The company's products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. Its laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture; and laminate caseworks that are used in educational, healthcare, and industrial applications. The company sells its products primarily through dealers, commissioned agents, and a national distributor, as well as through competitive bids submitted by the company and its subsidiaries in Singapore, India, and China. Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina.
Latest HUM
- Humana Names Dr. Shantanu Nundy as Chief Medical Officer
- James P. Holland to Join Humana as Medicaid President
- Humana upgraded by Morgan Stanley with a new price target
- Humana Subsidiary iCare Selected for Family Care and Family Care Partnership Contracts Across Southeast Wisconsin
- Director Smith Paul John was granted 544 units of Humana Common (SEC Form 4)
- Director Crawford Frederick John was granted 544 units of Humana Common (SEC Form 4)
- Humana upgraded by Evercore ISI with a new price target
- Humana upgraded by Leerink Partners with a new price target
- Humana downgraded by Raymond James
- New insider Crawford Frederick John claimed ownership of 21 units of Humana Common (SEC Form 3)
Latest KEQU
- Kewaunee Scientific Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2027
- SEC Form DEFA14A filed by Kewaunee Scientific Corporation
- SEC Form DEF 14A filed by Kewaunee Scientific Corporation
- SVP, People & Culture Phillips Elizabeth D converted options into 6,656 shares, returned $181,069 worth of shares to the company (4,995 units at $36.25) and covered exercise/tax liability with 793 shares, increasing direct ownership by 11% to 9,116 units (SEC Form 4)
- SVP, IT & Engineering Ranade Mandar converted options into 7,227 shares, returned $65,250 worth of shares to the company (1,800 units at $36.25) and covered exercise/tax liability with 1,877 shares, increasing direct ownership by 28% to 16,215 units (SEC Form 4)
- SVP, Sales & Marketing Dev Noble Ryan S. returned $108,750 worth of shares to the company (3,000 units at $36.25), covered exercise/tax liability with 1,809 shares and converted options into 7,206 shares, increasing direct ownership by 17% to 16,240 units (SEC Form 4)
- SVP, Manufacturing Operations Batdorff Douglas J. converted options into 7,451 shares, returned $203,326 worth of shares to the company (5,609 units at $36.25) and covered exercise/tax liability with 851 shares, increasing direct ownership by 14% to 8,170 units (SEC Form 4)
- Chief Financial Officer Gardner Donald T. Iii converted options into 21,265 shares, returned $435,000 worth of shares to the company (12,000 units at $36.25) and covered exercise/tax liability with 4,027 shares, increasing direct ownership by 55% to 14,802 units (SEC Form 4)
- President & CEO Hull Thomas David Iii converted options into 54,388 shares, returned $616,250 worth of shares to the company (17,000 units at $36.25) and covered exercise/tax liability with 16,243 shares, increasing direct ownership by 64% to 54,145 units (SEC Form 4)